These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28763425)

  • 1. Frequency of Acute Otitis Media in Children Under 24 Months of Age Before and After the Introduction of the 10-valent Pneumococcal Conjugate Vaccine Into the National Immunization Program in Chile.
    Rosenblut A; Rosenblut M; García K; Maul X; Santolaya ME
    Pediatr Infect Dis J; 2018 Feb; 37(2):132-134. PubMed ID: 28763425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pneumococcal conjugate vaccines on incidence and microbiology associated with complicated acute otitis media.
    Laursen BB; Danstrup CS; Hoffmann S; Nørskov-Lauritsen N; Christensen ALB; Ovesen T
    Int J Pediatr Otorhinolaryngol; 2017 Oct; 101():249-253. PubMed ID: 28964304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Acute Otitis Media With Treatment Failure After Introduction of the Ten-valent Pneumococcal Haemophilus influenzae Protein D Conjugate Vaccine.
    Eythorsson E; Hrafnkelsson B; Erlendsdóttir H; Gudmundsson SA; Kristinsson KG; Haraldsson Á
    Pediatr Infect Dis J; 2018 Apr; 37(4):361-366. PubMed ID: 29278616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of acute otitis media, recurrent otitis media and tympanostomy tube insertion in children after its implementation into the national immunization program in Turkey.
    Soysal A; Gönüllü E; Yıldız I; Aydemir G; Tunç T; Fırat Y; Erdamar B; Karaböcüoğlu M
    Hum Vaccin Immunother; 2020; 16(2):445-451. PubMed ID: 31424317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of acute otitis media otopathogens before the introduction of the pneumococcal conjugated vaccine into the national immunization program in Poland.
    Górska-Kot A; Greenberg D; Gastoł K; Zieliński A; Givon-Lavi N
    Int J Pediatr Otorhinolaryngol; 2019 Dec; 127():109666. PubMed ID: 31491733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric Acute Otitis Media in the Era of Pneumococcal Vaccination.
    Tawfik KO; Ishman SL; Altaye M; Meinzen-Derr J; Choo DI
    Otolaryngol Head Neck Surg; 2017 May; 156(5):938-945. PubMed ID: 28349737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era.
    Kaur R; Morris M; Pichichero ME
    Pediatrics; 2017 Sep; 140(3):. PubMed ID: 28784702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current face of acute otitis media: microbiology and prevalence resulting from widespread use of heptavalent pneumococcal conjugate vaccine.
    Brunton S
    Clin Ther; 2006 Jan; 28(1):118-23. PubMed ID: 16490585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving microbiology of complicated acute otitis media before and after introduction of the pneumococcal conjugate vaccine in France.
    Dupont D; Mahjoub-Messai F; François M; Doit C; Mariani-Kurkdjian P; Bidet P; Bonacorsi S; Carol A; Bingen E
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):89-92. PubMed ID: 20727478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence of admissions due to pneumonia in children under 24 months old before and after the introduction of the 10-valent pneumococcal conjugate vaccine into the National Immunization Program of Chile].
    Fernández V JP; Goecke H C; von Borries C; Tapia R N; Santolaya de P ME
    Rev Chil Pediatr; 2015; 86(3):168-72. PubMed ID: 26363857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses.
    Suarez V; Michel F; Toscano CM; Bierrenbach AL; Gonzales M; Alencar AP; Ruiz Matus C; Andrus JK; de Oliveira LH
    Vaccine; 2016 Sep; 34(39):4738-4743. PubMed ID: 27521230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of Streptococcus pneumoniae in upper respiratory tract cultures and a decreased incidence of related acute otitis media following introduction of childhood pneumococcal conjugate vaccines in a Swedish county.
    Littorin N; Ahl J; Uddén F; Resman F; Riesbeck K
    BMC Infect Dis; 2016 Aug; 16(1):407. PubMed ID: 27514843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme.
    Wouters I; Van Heirstraeten L; Desmet S; Blaizot S; Verhaegen J; Goossens H; Van Damme P; Malhotra-Kumar S; Theeten H;
    Vaccine; 2018 Jan; 36(1):15-22. PubMed ID: 29180027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of randomized controlled trials on pneumococcal vaccination for prevention of otitis media.
    Straetemans M; Sanders EA; Veenhoven RH; Schilder AG; Damoiseaux RA; Zielhuis GA
    Pediatr Infect Dis J; 2003 Jun; 22(6):515-24. PubMed ID: 12799508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation.
    Cohen R; Varon E; Doit C; Schlemmer C; Romain O; Thollot F; Béchet S; Bonacorsi S; Levy C
    Vaccine; 2015 Sep; 33(39):5118-26. PubMed ID: 26271823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution, dynamics and antibiotic resistance patterns of Streptococcus pneumoniae serotypes causing acute otitis media in children in southern Israel during the 10 year-period before the introduction of the 7-valent pneumococcal conjugate vaccine.
    Somech I; Dagan R; Givon-Lavi N; Porat N; Raiz S; Leiberman A; Puterman M; Peled N; Greenberg D; Leibovitz E
    Vaccine; 2011 Jun; 29(25):4202-9. PubMed ID: 21497634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptococcus pneumoniae serotypes isolated from the middle ear fluid of Costa Rican children following introduction of the heptavalent pneumococcal conjugate vaccine into a limited population.
    Guevara S; Abdelnour A; Soley C; Porat N; Dagan R; Arguedas A
    Vaccine; 2012 Jun; 30(26):3857-61. PubMed ID: 22521846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.
    Kilpi T; Ahman H; Jokinen J; Lankinen KS; Palmu A; Savolainen H; Grönholm M; Leinonen M; Hovi T; Eskola J; Käyhty H; Bohidar N; Sadoff JC; Mäkelä PH;
    Clin Infect Dis; 2003 Nov; 37(9):1155-64. PubMed ID: 14557958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overall effectiveness of pneumococcal conjugate vaccines: An economic analysis of PHiD-CV and PCV-13 in the immunization of infants in Italy.
    Castiglia P; Pradelli L; Castagna S; Freguglia V; Palù G; Esposito S
    Hum Vaccin Immunother; 2017 Oct; 13(10):2307-2315. PubMed ID: 28700264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.